Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

A 75-year-old woman was diagnosed with c-ros oncogene 1 (ROS1)-positive lung adenocarcinoma. She was treated with crizotinib 750 mg/day for 4.5 years, with partial tumor response. However, the patient subsequently presented with right hip pain and difficulty in walking. She underwent magnetic resona...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Oba, Taro, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975501/
https://www.ncbi.nlm.nih.gov/pubmed/32021222
http://dx.doi.org/10.2147/TCRM.S229860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975501/
https://www.ncbi.nlm.nih.gov/pubmed/32021222
http://dx.doi.org/10.2147/TCRM.S229860

Ejemplares similares